Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Thoracic 2Genitourinary 2Plasma cell 1Dermatologic 1

Conditions

Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
tetrathiomolybdate × Gastrointestinal × Clear all
NCT00176800 2016-08-22

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Completed
69 enrolled 7 charts
Gastrointestinal

Esophageal Neoplasms

NCT00176774 2012-02-07

Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Completed
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00006332 2005-06-24

Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate

National Center for Research Resources (NCRR)

Phase 2 Completed
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡